Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor

Enzymatically-produced oligodendrocyte cytotoxic dimeric IL-2 factor

US Patent 5962404 · Granted Oct 5, 1999

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023
Reducing systemic regulatory t cell levels or activity for treatment of disease 2022
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2021
Reducing systemic regulatory T cell levels or activity for treatment of disease 2021
Reducing systemic regulatory T cell levels or activity for treatment of disease 2021
Reducing systemic regulatory T cell levels or activity for treatment of disease 2020
Reducing systemic regulatory T cell levels or activity for treatment of disease 2019
Reducing systemic regulatory T cell levels or activity for treatment of disease 2019
Human monocyte sub-population for treatment of eye diseases and disorders2019